Eosinophilic oesophagitis (EoE) is still inadequately treated in terms of its association with other type 2 inflammatory diseases (T2). Italian researchers attempted to close this gap. Their conclusion: In EoE patients, it is no longer sufficient to rely on medical history or isolated specialist input. A structured, multidisciplinary assessment improves diagnostic accuracy, identifies therapeutic targets and enables a more individualized treatment plan.
Autoren
- Jens Dehn
Publikation
- GASTROENTEROLOGIE PRAXIS
Related Topics
You May Also Like
- The Brain and the Motivation to Eat
Why is it so hard to lose weight?
- Cardiology and Nutrition
Ultra-Processed Foods and Cardiovascular Risk—The New AHA Position Statement
- Breast (HR+) and Endometrial Cancer
A Comparison of Hormone-Dependent Female Tumors
- Chronic Urticaria: Treatment for Patients Unresponsive to Antihistamines
In addition to anti-IgE antibodies, the guideline recommends anti-IL-4α antibodies and BTK inhibition
- Type 1 Diabetes in Childhood
Early Impairment of Glucagon Counterregulation
- Psychosis in Parkinson's Disease
Be Careful When Choosing Medications
- Esophageal Cancer
A Comparison of Endoscopic and Surgical Innovations
- PMR and LVV: Current EULAR Recommendations